Linden Thomas Advisory Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Sell |
116,115
-1,166
| -1% | -$32.3K | 0.35% | 74 |
|
|
2025
Q1 | $2.6M | Sell |
117,281
-323
| -0.3% | -$7.17K | 0.34% | 80 |
|
|
2024
Q4 | $2.33M | Sell |
117,604
-106
| -0.1% | -$2.1K | 0.29% | 99 |
|
|
2024
Q3 | $2.94M | Sell |
117,710
-592
| -0.5% | -$14.8K | 0.4% | 55 |
|
|
2024
Q2 | $2.21M | Buy |
118,302
+1,921
| +2% | +$35.9K | 0.34% | 72 |
|
|
2024
Q1 | $2.3M | Buy |
116,381
+1,831
| +2% | +$36.1K | 0.37% | 61 |
|
|
2023
Q4 | $2.01M | Sell |
114,550
-1,341
| -1% | -$23.5K | 0.38% | 66 |
|
|
2023
Q3 | $2.01M | Buy |
115,891
+57,942
| +100% | +$1.01M | 0.45% | 45 |
|
|
2023
Q2 | $816K | Buy |
+57,949
| New | +$816K | 0.18% | 230 |
|